Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Divestments (2023)

Bioventus' Divestments history spans 1 years, with the latest figure at -$46.4 million for Q4 2023.

  • For Q4 2023, Divestments changed N/A year-over-year to -$46.4 million; the TTM value through Sep 2024 reached -$46.4 million, down 232.97%, while the annual FY2023 figure was -$11.5 million, N/A changed from the prior year.
  • Divestments reached -$46.4 million in Q4 2023 per BVS's latest filing, down from $46.4 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $46.4 million in Q3 2023 to a low of -$46.4 million in Q4 2023.